Mechanisms of Action of Surgical Interventions on Weight-Related Diseases: the Potential Role of Bile Acids (Q39090294)

9 September 2017

Mechanisms of Action of Surgical Interventions on Weight-Related Diseases: the Potential Role of Bile Acids (English)

1 reference

9 September 2017

surgical intervention

1 reference

Mohsen Mazidi

1

1 reference

9 September 2017

Pedro Paulo P de Caravatto

series ordinal

2

1 reference

9 September 2017

John R Speakman

series ordinal

3

1 reference

9 September 2017

Ricardo V Cohen

series ordinal

4

1 reference

9 September 2017

14 January 2017

1 reference

9 September 2017

1 reference

9 September 2017

27

1 reference

9 September 2017

826-836

1 reference

9 September 2017

3

1 reference

https://scigraph.springernature.com/pub.10.1007/s11695-017-2549-1

9 September 2017

0 references

cites work

The effectiveness and risks of bariatric surgery: an updated systematic review and meta-analysis, 2003-2012

1 reference

https://api.crossref.org/works/10.1007%2FS11695-017-2549-1

Bariatric surgery: results in obesity and effects on metabolic parameters.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11695-017-2549-1

Metabolic improvement of morbid obese patients following Roux-en-Y gastric bypass surgery: A prospective study in Mashhad, Iran

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11695-017-2549-1

The importance of caloric restriction in the early improvements in insulin sensitivity after Roux-en-Y gastric bypass surgery

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11695-017-2549-1

Gastric bypass surgery alters behavioral and neural taste functions for sweet taste in obese rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11695-017-2549-1

Gastric bypass increases ethanol and water consumption in diet-induced obese rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11695-017-2549-1

Dipeptidyl peptidase IV inhibitors: a promising new therapeutic approach for the management of type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11695-017-2549-1

Duodenal-jejunal exclusion improves glucose tolerance in the diabetic, Goto-Kakizaki rat by a GLP-1 receptor-mediated mechanism.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11695-017-2549-1

Endocrine functions of bile acids

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11695-017-2549-1

The mechanism of diabetes control after gastrointestinal bypass surgery reveals a role of the proximal small intestine in the pathophysiology of type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11695-017-2549-1

Remission of type 2 diabetes after gastric bypass and banding: mechanisms and 2 year outcomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11695-017-2549-1

Gut hormones as mediators of appetite and weight loss after Roux-en-Y gastric bypass.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11695-017-2549-1

Who would have thought it? An operation proves to be the most effective therapy for adult-onset diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11695-017-2549-1

Peptide YY3-36 and glucagon-like peptide-17-36 inhibit food intake additively.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11695-017-2549-1

Bile acids: regulation of synthesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11695-017-2549-1

Bile acids, obesity, and the metabolic syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11695-017-2549-1

A role for fibroblast growth factor 19 and bile acids in diabetes remission after Roux-en-Y gastric bypass

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11695-017-2549-1

FGF19 as a postprandial, insulin-independent activator of hepatic protein and glycogen synthesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11695-017-2549-1

Circulating intestinal fibroblast growth factor 19 has a pronounced diurnal variation and modulates hepatic bile acid synthesis in man.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11695-017-2549-1

FGF19 regulates cell proliferation, glucose and bile acid metabolism via FGFR4-dependent and independent pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11695-017-2549-1

The role of gut adaptation in the potent effects of multiple bariatric surgeries on obesity and diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11695-017-2549-1

Role of bile acids in the regulation of the metabolic pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11695-017-2549-1

Critical illness evokes elevated circulating bile acids related to altered hepatic transporter and nuclear receptor expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11695-017-2549-1

Coordinated induction of bile acid detoxification and alternative elimination in mice: role of FXR-regulated organic solute transporter-alpha/beta in the adaptive response to bile acids

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11695-017-2549-1

Role of farnesoid X receptor in cholestasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11695-017-2549-1

Loss of functional farnesoid X receptor increases atherosclerotic lesions in apolipoprotein E-deficient mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11695-017-2549-1

Activation of farnesoid X receptor prevents atherosclerotic lesion formation in LDLR-/- and apoE-/- mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11695-017-2549-1

The farnesoid X-receptor is an essential regulator of cholesterol homeostasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11695-017-2549-1

FXR deficiency causes reduced atherosclerosis in Ldlr-/- mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11695-017-2549-1

Bile acids lower triglyceride levels via a pathway involving FXR, SHP, and SREBP-1c

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11695-017-2549-1

Bile acids promote glucagon-like peptide-1 secretion through TGR5 in a murine enteroendocrine cell line STC-1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11695-017-2549-1

TGR5-mediated bile acid sensing controls glucose homeostasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11695-017-2549-1

FXR activation reverses insulin resistance and lipid abnormalities and protects against liver steatosis in Zucker (fa/fa) obese rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11695-017-2549-1

Farnesoid X receptor is essential for normal glucose homeostasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11695-017-2549-1

Activation of the nuclear receptor FXR improves hyperglycemia and hyperlipidemia in diabetic mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11695-017-2549-1

The role of bile after Roux-en-Y gastric bypass in promoting weight loss and improving glycaemic control

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11695-017-2549-1

Conjugated bile acids promote ERK1/2 and AKT activation via a pertussis toxin-sensitive mechanism in murine and human hepatocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11695-017-2549-1

Bile acids enhance the activity of the insulin receptor and glycogen synthase in primary rodent hepatocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11695-017-2549-1

Molecular mechanisms underlying bile acid-stimulated glucagon-like peptide-1 secretion

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11695-017-2549-1

Rectal taurocholate increases L cell and insulin secretion, and decreases blood glucose and food intake in obese type 2 diabetic volunteers

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11695-017-2549-1

Oleic acid and peanut oil high in oleic acid reverse the inhibitory effect of insulin production of the inflammatory cytokine TNF-alpha both in vitro and in vivo systems

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11695-017-2549-1

Bile acids induce energy expenditure by promoting intracellular thyroid hormone activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11695-017-2549-1

Postprandial plasma bile acid responses in normal weight and obese subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11695-017-2549-1

Roux-en-Y gastric bypass normalizes the blunted postprandial bile acid excursion associated with obesity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11695-017-2549-1

Novel potent and selective bile acid derivatives as TGR5 agonists: biological screening, structure-activity relationships, and molecular modeling studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11695-017-2549-1

Diet-induced thermogenesis and respiratory quotient after Roux-en-Y gastric bypass

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11695-017-2549-1

Surgical weight loss: impact on energy expenditure

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11695-017-2549-1

Long-limb gastric bypass in the superobese. A prospective randomized study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11695-017-2549-1

Weight loss after extended gastric bypass.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11695-017-2549-1

Long-long limb Roux-en-Y gastric bypass is more efficacious in treatment of type 2 diabetes and lipid disorders in super-obese patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11695-017-2549-1

The impact of roux limb length on weight loss after gastric bypass

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11695-017-2549-1

Effect of standard vs extended Roux limb length on weight loss outcomes after laparoscopic Roux-en-Y gastric bypass

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11695-017-2549-1

Weight gain after short- and long-limb gastric bypass in patients followed for longer than 10 years.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11695-017-2549-1

Conversion of proximal to distal gastric bypass for failed gastric bypass for superobesity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11695-017-2549-1

The malabsorptive very, very long limb Roux-en-Y gastric bypass for super obesity: results in 257 patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11695-017-2549-1

Gastrointestinal hormones and bariatric surgery-induced weight loss

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11695-017-2549-1

Serum bile acids are higher in humans with prior gastric bypass: potential contribution to improved glucose and lipid metabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11695-017-2549-1

Bile acids and gut peptide secretion after bariatric surgery: a 1-year prospective randomized pilot trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11695-017-2549-1

Obese patients after gastric bypass surgery have lower brain-hedonic responses to food than after gastric banding.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11695-017-2549-1

Enhanced fasting and post-prandial plasma bile acid responses after Roux-en-Y gastric bypass surgery.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11695-017-2549-1

Bariatric surgery modulates circulating and cardiac metabolites.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11695-017-2549-1

Conjugated bile acids associate with altered rates of glucose and lipid oxidation after Roux-en-Y gastric bypass

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11695-017-2549-1

Gut hormones, early dumping and resting energy expenditure in patients with good and poor weight loss response after Roux-en-Y gastric bypass.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11695-017-2549-1

Laparoscopic sleeve gastrectomy differentially affects serum concentrations of FGF-19 and FGF-21 in morbidly obese subjects.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11695-017-2549-1

Prospective study of gut hormone and metabolic changes after adjustable gastric banding and Roux-en-Y gastric bypass

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11695-017-2549-1

Incretin levels and effect are markedly enhanced 1 month after Roux-en-Y gastric bypass surgery in obese patients with type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11695-017-2549-1

Glucagon-like peptide-1, peptide YY, hunger, and satiety after gastric bypass surgery in morbidly obese subjects.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11695-017-2549-1

Long-term effects of Roux-en-Y gastric bypass surgery on plasma glucagon-like peptide-1 and islet function in morbidly obese subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11695-017-2549-1

Resting energy expenditure and energetic cost of feeding are augmented after Roux-en-Y gastric bypass in obese mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11695-017-2549-1

Comparison of glucostatic parameters after hypocaloric diet or bariatric surgery and equivalent weight loss

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11695-017-2549-1

Serum bile acid along with plasma incretins and serum high-molecular weight adiponectin levels are increased after bariatric surgery.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11695-017-2549-1

Nutritional regulation of bile acid metabolism is associated with improved pathological characteristics of the metabolic syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11695-017-2549-1

Dissociation of intestinal and hepatic activities of FXR and LXRα supports metabolic effects of terminal ileum interposition in rodents.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11695-017-2549-1

Are bile acids the new gut hormones? Lessons from weight loss surgery models.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11695-017-2549-1

A surgical model in male obese rats uncovers protective effects of bile acids post-bariatric surgery.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11695-017-2549-1

Energy balance measurement: when something is not better than nothing

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11695-017-2549-1

FXR is a molecular target for the effects of vertical sleeve gastrectomy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11695-017-2549-1

Effects of postbariatric surgery weight loss on adipokines and metabolic parameters: comparison of laparoscopic Roux-en-Y gastric bypass and laparoscopic sleeve gastrectomy--a prospective randomized trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11695-017-2549-1

FXR signaling in metabolic disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11695-017-2549-1

Weight loss induced by Roux-en-Y gastric bypass but not laparoscopic adjustable gastric banding increases circulating bile acids.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11695-017-2549-1

Clinical utility of bile acid sequestrants in the treatment of dyslipidemia: a scientific review

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11695-017-2549-1

Effect of bile acid sequestrants on glucose metabolism, hepatic de novo lipogenesis, and cholesterol and bile acid kinetics in type 2 diabetes: a randomised controlled study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11695-017-2549-1

Colesevelam HCl improves glycemic control and reduces LDL cholesterol in patients with inadequately controlled type 2 diabetes on sulfonylurea-based therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11695-017-2549-1

Efficacy and safety of colesevelam in patients with type 2 diabetes mellitus and inadequate glycemic control receiving insulin-based therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11695-017-2549-1

Colesevelam improves insulin resistance in a diet-induced obesity (F-DIO) rat model by increasing the release of GLP-1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11695-017-2549-1

Colestimide lowers plasma glucose levels and increases plasma glucagon-like PEPTIDE-1 (7-36) levels in patients with type 2 diabetes mellitus complicated by hypercholesterolemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11695-017-2549-1

Bile acid binding resin improves metabolic control through the induction of energy expenditure

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11695-017-2549-1

TGR5 potentiates GLP-1 secretion in response to anionic exchange resins

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11695-017-2549-1

FXR signaling in the enterohepatic system

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11695-017-2549-1

The bile acid TGR5 membrane receptor: from basic research to clinical application

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11695-017-2549-1

The bile acid membrane receptor TGR5: a novel pharmacological target in metabolic, inflammatory and neoplastic disorders.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11695-017-2549-1

Bile acid sequestrants and the treatment of type 2 diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11695-017-2549-1

Plasma bile acids are not associated with energy metabolism in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11695-017-2549-1

Improved glycemic control with colesevelam treatment in patients with type 2 diabetes is not directly associated with changes in bile acid metabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11695-017-2549-1

Plasma Bile Acids Are Associated with Energy Expenditure and Thyroid Function in Humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11695-017-2549-1

Inhibition of the activity of dipeptidyl-peptidase IV as a treatment for type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11695-017-2549-1

The effectiveness of gastric bypass over gastric partition in morbid obesity: consequence of distal gastric and duodenal exclusion

21 January 2018

1 reference

12 December 2020

How the hindgut can cure type 2 diabetes. Ileal transposition improves glucose metabolism and beta-cell function in Goto-kakizaki rats through an enhanced Proglucagon gene expression and L-cell number

1 reference

12 December 2020

Antiatherosclerotic effect of farnesoid X receptor

1 reference

12 December 2020

Common channel length predicts outcomes of biliopancreatic diversion alone and with the duodenal switch surgery

1 reference

12 December 2020

Metabolic profiling of the human response to a glucose challenge reveals distinct axes of insulin sensitivity

1 reference

12 December 2020

Adding malabsorption for weight loss failure after gastric bypass.

1 reference

12 December 2020

A meta-analysis of the effect of glucagon-like peptide-1 (7-36) amide on ad libitum energy intake in humans.

1 reference

12 December 2020

Bariatric surgery for treatment of obesity

1 reference

12 December 2020

Long- or short-limb gastric bypass?

1 reference

12 December 2020

The enterohepatic circulation of bile acids in mammals: form and functions

1 reference

12 December 2020

Anti-hyperglycemic activity of a TGR5 agonist isolated from Olea europaea

1 reference

12 December 2020

Malabsorptive gastric bypass in patients with superobesity

1 reference

12 December 2020

Treatment with GLP1 receptor agonists reduce serum CRP concentrations in patients with type 2 diabetes mellitus: A systematic review and meta-analysis of randomized controlled trials

1 reference

12 December 2020

Gastric bypass in obesity

1 reference

12 December 2020

Biliopancreatic diversion for obesity at eighteen years

1 reference

12 December 2020

Long-term changes in energy expenditure and body composition after massive weight loss induced by gastric bypass surgery.

1 reference

12 December 2020

Alterations of hormonally active fibroblast growth factors after Roux-en-Y gastric bypass surgery

1 reference

12 December 2020

10.1007/S11695-017-2549-1

Identifiers

DOI

1 reference

9 September 2017

1 reference